A Study of Anal Cancer Development in HIV Infected People

NCT00107679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2014-04-17

No results posted yet for this study

Summary

The purpose of this study is to compare the development of abnormal cell growth or cancer in the anal region of individuals who are receiving one of two different anti-HIV treatment strategies.

Conditions

  • HIV Infections
  • Anus Neoplasms

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Calvin Cohen, MD, MSc · Community Research Initiative of New England

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00107679 on ClinicalTrials.gov